Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
10/2014
10/02/2014US20140296533 Process for the preparation of 4-amino-5-fluoro-3-chloro-6-(substituted)picolinates
10/02/2014US20140296304 Pharmaceutically Active Disubstituted Pyridine Derivatives
10/02/2014US20140296295 2-alkoxy-substituted dicyanopyridines and their use
10/02/2014US20140296249 4-phenylpiperazine derivatives with functionalized linkers as dopamine d3 receptor selective ligands and methods of use
10/02/2014US20140296240 Substituted aminopropionic derivatives as neprilysin inhibitors
10/02/2014US20140295045 Pyridine Derivatives With Umami Flavour
10/01/2014EP2784065A1 Glycine reuptake inhibitor and use thereof
09/2014
09/30/2014US8846948 Compounds
09/30/2014US8846937 Mono quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors
09/30/2014US8846936 Sulfonyl compounds which modulate the CB2 receptor
09/30/2014US8846933 N-link hydroxamic acid derivatives useful as antibacterial agents
09/30/2014US8846932 Small molecules modulator of epigenetic regulation and their therapeutic applications
09/30/2014US8846931 Bipyridyl derivatives
09/30/2014US8846928 Benzamides and nicotinamides as Syk modulators
09/30/2014US8846721 Compositions for reducing aβ 42 production and their use in treating alzheimer's disease (AD)
09/30/2014US8846707 Substituted 2-hydroxy-4-(2-(phenylsulfonamido)acetamido)benzoic acid analogs as inhibitors of stat protein
09/30/2014US8846569 Pesticidal bis-organosulfur compounds
09/30/2014US8846291 Resist composition, method of forming resist pattern, and new compound
09/30/2014US8846214 Amine derivative and organic electroluminescent element
09/30/2014US8846012 Melanin production inhibitor
09/30/2014CA2664579C 2-aminocarbonyl-pyridine derivatives
09/25/2014WO2014152588A1 Covalent inhibitors of kras g12c
09/25/2014WO2014152453A2 Continuous flow synthesis of dithioester compounds
09/25/2014WO2014152270A1 Salt of omecamtiv mecarbil and process for preparing salt
09/25/2014WO2014152236A1 Heterocyclic compounds and their uses
09/25/2014WO2014151945A1 Histone demethylase inhibitors
09/25/2014WO2014151616A1 Biaryl amide compounds as kinase inhibitors
09/25/2014WO2014151517A1 Methods of improving microvascular integrity
09/25/2014WO2014150677A1 Inhibitors of indoleamine 2,3-dioxygenase (ido)
09/25/2014WO2014148053A1 Use of ep4 receptor antagonists in the treatment of cartilage disease
09/25/2014WO2014147021A2 Novel compounds
09/25/2014WO2014146581A1 Method for preparing acrylate compound
09/25/2014US20140288308 Novel processes for the manufacture of propane-1-sulfonic acid -amide
09/25/2014US20140288306 Process for preparing amines from alcohols and ammonia
09/25/2014US20140288132 Hydroxybenzoate salts of metanicotine compounds
09/25/2014US20140288123 Modulators of methyl modifying enzymes, compositions and uses thereof
09/25/2014US20140288092 Heteroaryl compounds as sodium channel blockers
09/25/2014US20140288086 Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
09/25/2014US20140288045 Covalent inhibitors of kras g12c
09/25/2014US20140288041 Aryl- or Heteroaryl-Substituted Benzene Compounds
09/25/2014US20140288017 Catechol diethers as potent anti-hiv agents
09/24/2014EP2781516A2 New crystalline forms of the sodium salt of (4- {4- [5- ( 6 - trifluoromethyl - pyridin- 3 - ylamino ) - pyridin- 2 -yl]-phenyl} - cyclohexyl) -acetic acid
09/23/2014US8841483 Compositions useful as inhibitors of voltage-gated sodium channels
09/23/2014US8841460 Tunable phenylacetylene hosts
09/23/2014US8841459 3-arylamino pyridine derivatives
09/23/2014US8841458 Compound containing pyridine ring and method for producing halogenated picoline derivative and tetrazolyloxime derivative
09/23/2014US8841457 Process for cyclooxygenase-2 selective inhibitor
09/23/2014US8841336 Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists
09/23/2014US8841331 Inhibitors of human immunodeficiency virus replication
09/23/2014US8841330 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
09/23/2014US8841323 1, 4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of MGLUR2-receptors
09/23/2014US8841313 CCR2 antagonists and uses thereof
09/23/2014US8841290 Substituted tetrahydronaphthalenes, method for the production thereof, and use thereof as drugs
09/23/2014US8841276 Fulvene and fulvalene analogs and their use in treating cancers
09/23/2014US8840866 Styrylpyridine derivatives and their use for binding and imaging amyloid plaques
09/23/2014US8840865 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof
09/18/2014WO2014145040A1 Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
09/18/2014WO2014144669A2 Tension systems and methods of use
09/18/2014WO2014144197A1 Stereodynamic chemosensors
09/18/2014WO2014142547A1 Phenyl carbamate compound and a composition for neuroprotection comprising the same
09/18/2014WO2014141187A1 Pyridine derivatives as rearranged during transfection (ret) kinase inhibitors
09/18/2014WO2014141175A1 Novel acrylamide derivatives as antimalarial agents
09/18/2014WO2014139465A1 Novel pyrimidine and pyridine compounds and their usage
09/18/2014WO2014138905A1 Forms of sorafenib tosylate and processes for the preparation thereof
09/18/2014US20140275551 Process for the preparation of roflumilast
09/18/2014US20140275543 Stabilized compositions and methods of manufacture
09/18/2014US20140275152 Compounds and uses thereof for the modulation of hemoglobin
09/18/2014US20140275132 Pyridinyl and pyrimidinyl sulfonamide derivatives as chemokine receptor modulators
09/18/2014US20140275111 Novel compounds as rearranged during transfection (ret) inhibitors
09/18/2014US20140275108 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
09/18/2014US20140275060 Compounds for the treatment of neurologic disorders
09/18/2014US20140275057 Novel compounds and compositions for the inhibition of nampt
09/18/2014US20140275043 Substituted 3-phenylpropylamine derivatives for the treatment of ophthalmic diseases and disorders
09/18/2014US20140275037 Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
09/18/2014US20140275008 Compounds and uses thereof for the modulation of hemoglobin
09/18/2014US20140275003 Biaryl amide compounds as kinase inhibitors
09/18/2014US20140271591 Compositions and methods for the modulation of hemoglobin (s)
09/18/2014US20140264312 Novel organic compound and organic light-emitting device
09/18/2014US20140262818 Processes for preparing n-ethyl-2-methylpyridinium bromide and n-ethyl-3-methylpyridinium bromide
09/17/2014EP2778156A1 Phenoxypyridinylamide derivatives and their use in the treatment of PDE4 mediated disease states
09/17/2014EP2778155A1 2-aminopyridine derivatives useful as kinase inhibitors
09/17/2014EP2776605A1 Environmentally friendly corrosion inhibitors
09/17/2014EP2776396A2 Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
09/17/2014EP2776395A2 Process for the preparation of roflumilast
09/17/2014EP2776394A1 (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors
09/17/2014EP2776387A1 Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction
09/17/2014EP2776029A1 Treatment of ovarian cancer with benzylidenebenzohydrazides
09/16/2014US8835691 Process for homogeneously catalyzed, highly selective direct amination of primary alcohols with ammonia to primary amines with a high volume ratio of liquid phase to gas phase and/or high pressures
09/16/2014US8835689 Substituted 4-aminocyclohexane derivatives
09/16/2014US8835649 Method of synthesizing organic molecules using ionic liquids comprising a carbanion
09/16/2014US8835643 Molecules, compositions, and methods for light absorption
09/16/2014US8835491 Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance
09/16/2014US8835472 Compounds, pharmaceutical compositions and uses thereof
09/16/2014US8835467 SIR2 regulation
09/16/2014US8835463 Compounds having analgesic and/or immunostimulant activity
09/16/2014US8835444 Cyclohexyl amide derivatives as CRF receptor antagonists
09/16/2014US8835409 3-alkenyl-6-halo-4-aminopicolinates and their use as herbicides
09/16/2014CA2650970C P38 map kinase inhibitors
09/16/2014CA2650342C Chromium complexes
09/12/2014WO2014138460A1 2-aminopyridine-based selective neuronal nitric oxide synthase inhibitors
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 633